Re condoms: I think you'll find that Vivagel condoms are more of a retail product anyway rather than being something that doctors recommend - so i'm not worried.
I obviously can't argue against the hearsay of your female doctor - but I will say that she is a doctor and not a scientist, so maybe isn't familiar with dendrimer technology but who knows.
-
Can't comment on BV treatment competitor products but it's a multi-million dollar market (+/-$350m just in EU) so I still look forward to seeing revenue in 2016.
As far as I understand there are currently no BV cure products on the market (as opposed to treatment) so will be good if SPL can launch this product as well.
Condoms down the drain..., page-17
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.006(6.06%) |
Mkt cap ! $41.81M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $42.85K | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 247015 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |